Matches in Wikidata for { <http://www.wikidata.org/entity/Q86272935> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q86272935 description "clinical trial" @default.
- Q86272935 description "ensayu clínicu" @default.
- Q86272935 description "klinisch onderzoek" @default.
- Q86272935 description "клінічне випробування" @default.
- Q86272935 name "FT596 as a Monotherapy and in Combination With Anti-CD20 Monoclonal Antibodies" @default.
- Q86272935 name "FT596 as a Monotherapy and in Combination With Anti-CD20 Monoclonal Antibodies" @default.
- Q86272935 type Item @default.
- Q86272935 label "FT596 as a Monotherapy and in Combination With Anti-CD20 Monoclonal Antibodies" @default.
- Q86272935 label "FT596 as a Monotherapy and in Combination With Anti-CD20 Monoclonal Antibodies" @default.
- Q86272935 prefLabel "FT596 as a Monotherapy and in Combination With Anti-CD20 Monoclonal Antibodies" @default.
- Q86272935 prefLabel "FT596 as a Monotherapy and in Combination With Anti-CD20 Monoclonal Antibodies" @default.
- Q86272935 P1050 Q86272935-1E091EA3-A96C-4AEA-8BBB-4C991E698586 @default.
- Q86272935 P1050 Q86272935-B488C4B5-2956-44B8-8954-CC290830A4C0 @default.
- Q86272935 P1132 Q86272935-F91C4D23-E03C-4E3B-9921-8CAE002BE2A8 @default.
- Q86272935 P1476 Q86272935-86B71199-B936-496B-ADC5-0A93131ECA7E @default.
- Q86272935 P2899 Q86272935-9A1D77AA-F6CC-46B4-BC05-E1491B48EC1C @default.
- Q86272935 P3098 Q86272935-06CA19BE-C2DF-4720-9BAF-CEFA0F75E4DE @default.
- Q86272935 P31 Q86272935-A80300BE-B2ED-47E7-878E-AF79569415B2 @default.
- Q86272935 P4844 Q86272935-27F408ED-36F8-4B30-AE32-E6AA4E3EC7CB @default.
- Q86272935 P4844 Q86272935-4BEBCD82-39D5-4A8E-92FD-BE9C8EA50807 @default.
- Q86272935 P4844 Q86272935-9FB10158-55D6-484E-B829-0F9D2E1BDBCE @default.
- Q86272935 P4844 Q86272935-D2A59D13-3FD9-4C00-9CEE-511D528F2864 @default.
- Q86272935 P580 Q86272935-F30BB3BB-B249-4621-8871-8EE57322356E @default.
- Q86272935 P582 Q86272935-A6AC3779-04C4-403C-8362-D3BE3BFE95DF @default.
- Q86272935 P6099 Q86272935-055F9A98-7D14-4B11-AFC2-2488C0B5E189 @default.
- Q86272935 P8363 Q86272935-3640A6CE-06E7-4D85-BE3B-DC5B786B7F50 @default.
- Q86272935 P1050 Q208414 @default.
- Q86272935 P1050 Q29496 @default.
- Q86272935 P1132 "+123" @default.
- Q86272935 P1476 "A Phase I, Open-Label, Multicenter Study of FT596 as a Monotherapy and in Combination With Rituximab or Obinutuzumab in Subjects With Relapsed/Refractory B-cell Lymphoma and Chronic Lymphocytic Leukemia" @default.
- Q86272935 P2899 "+18" @default.
- Q86272935 P3098 "NCT04245722" @default.
- Q86272935 P31 Q30612 @default.
- Q86272935 P4844 Q185916 @default.
- Q86272935 P4844 Q389496 @default.
- Q86272935 P4844 Q408524 @default.
- Q86272935 P4844 Q412323 @default.
- Q86272935 P580 "2020-01-01T00:00:00Z" @default.
- Q86272935 P582 "2022-04-01T00:00:00Z" @default.
- Q86272935 P6099 Q5452194 @default.
- Q86272935 P8363 Q78089383 @default.